How does a widely used once-weekly diabetes medication affect blood sugar, stomach emptying, and post-meal blood pressure?
About the study
We are conducting a research study to understand how a widely used once-weekly medication affects blood sugar control in people with type 2 diabetes. This medication may lower post-meal blood sugar by slowing stomach emptying, but its precise effects have not yet been measured using the gold-standard technique, scintigraphy. By participating, you can help us measure how the medication affects stomach emptying, explore the link between stomach-emptying rate and post-meal blood pressure, and determine how long these effects last after stopping the medication. The study runs for 16 weeks, including three full study days (around 5 hours each) and weekly short visits (about 30 minutes) to receive the medication.
Eligibility requirements
You may be eligible to participate in this study if you:
- Are aged between 40 and 85 years
- Have type 2 diabetes
- Manage diabetes with diet and/or metformin only
Study participants must be able to attend the Clinical Research Facility at the Adelaide Health and Medical Sciences Building on North Terrace.
Recruitment timeline
Start of recruitment: Jan 2025
End of recruitment: Dec 2026
Benefits
Participation involves approximately 30 hours over the 16-week study. Volunteers will receive an honorarium of up to $700 upon completing the study, paid according to ethical committee approval.
To register your interest in taking part in this study, please contact the Study Co-ordinator on +61 402 593 400 or at researchdiabetes@adelaide.edu.au.
